A More Thoughtful Generation of Biotic Formulations Is Coming
Our first products are in active development. Formulation design, ingredient evaluation, and manufacturing partner assessment are underway. We are being deliberate — because getting this right matters more than getting it done quickly.
We do not publish speculative product details prior to launch readiness. What we can share is how we think — the principles that govern every formulation decision we make.
Our Product Principles
What We Can Share
While specific formulation details remain confidential ahead of launch, these six principles define how we approach every product in development.
01
Gut-Brain Pathway Targeting
Each formulation is designed with a specific biological rationale related to gut-brain axis function — not broad claims, but a reasoned hypothesis about a particular pathway and a measurable effect.
02
Bioavailability-Considered Delivery
Delivery format, encapsulation technology, and gastrointestinal transit are evaluated during formulation design. Active compounds need to reach the relevant site of action at an appropriate concentration.
03
Evidence-Anchored Ingredient Selection
Ingredients are selected on the basis of the scientific literature, not market trends. We evaluate evidence quality, study populations, dosing, and mechanistic plausibility before including an ingredient.
04
Designed for Consistent Real-World Use
Efficacy data from research settings is only relevant if products can be used consistently by real people. Format, palatability, and the economics of sustained use are part of the design brief.
05
Stringent Quality Requirements
Our manufacturing partner requirements include identity verification, potency testing, contamination screening, microbial limits, stability data, and full batch documentation — not as aspirations, but as baselines.
06
Clean-Label Formulation Principles
Excipients, fillers, and processing aids are selected with the same scrutiny as active ingredients. We avoid unnecessary additives and aim for formulations whose ingredient lists reflect the product's intent.
Intellectual Property
What Remains Confidential
Specific formulation compositions, ingredient ratios, strain selections, proprietary delivery technologies, and supplier relationships are not disclosed publicly prior to product launch. This is a standard practice in formulation development and reflects our obligation to protect the investment made in scientific and commercial development.
We understand this may be frustrating for those who wish to evaluate or partner with us. For qualified organisations — including potential manufacturing partners, ingredient suppliers, research collaborators, and distribution partners — more detailed information may be available under a non-disclosure agreement.
Who Can Request Confidential Information
- Contract manufacturers evaluating formulation compatibility
- Ingredient and technology suppliers assessing fit
- Research institutions exploring collaboration
- Distribution and commercial partners conducting due diligence
- Strategic investors with relevant sector focus
Stay Informed
Follow the Development Journey
We share updates on formulation milestones, manufacturing developments, and launch timelines with our registered list. No marketing noise — just substantive progress updates when there is something worth sharing.
Partner With Us
Can Your Organisation Help?
We are actively building relationships with manufacturing partners, ingredient suppliers, and research collaborators. If your organisation has capabilities relevant to biotic product development, we would like to hear from you.
We evaluate all partnership enquiries on the basis of capability, quality standards, and alignment with our evidence-led approach — not on the basis of existing commercial relationships.
Product information presented here is preliminary and subject to change before launch. WellThesis does not make therapeutic, health, or medical claims in relation to its products unless supported by applicable regulatory standards and approvals in the relevant market.